Chlorpromazine enhances quinolone activity against K. pneumoniae in vitro, particularly in quinolone-susceptible isolates. Although the observed effects are more limited in resistant strains, the findings indicate that CPZ may serve as a potential adjuvant to improve quinolone activity. Further studies are required to evaluate the clinical relevance of this approach.
Gün et al. (Sat,) studied this question.